Atibuclimab
Product Specifications
CAS Number
2417175-94-9
Target
TLR, TNF
Related Pathways
Immunology/Inflammation, Apoptosis
Purity
0.95
Bioactivity
Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region. Atibuclimab can be used to treat amyotrophic lateral sclerosis. Atibuclimab reduces LPS-induced disease and inhibits LPS-induced pro-inflammatory cytokine release, delaying the release of anti-inflammatory cytokine soluble TNF receptor type I.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
049980-01 10 µg
Methylcrotonoyl Coenzyme A Carboxylase 2 (MCCC2), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 049980-02 50 µg
Methylcrotonoyl Coenzyme A Carboxylase 2 (MCCC2), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 049980-03 100 µg
Methylcrotonoyl Coenzyme A Carboxylase 2 (MCCC2), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 049980-04 200 µg
Methylcrotonoyl Coenzyme A Carboxylase 2 (MCCC2), Recombinant, Human, His-Tag
Sign In for Pricing
View Details 